UK markets closed

Merck&Co Earnings Beat, Revenue Misses In Q4

Merck&Co Earnings Beat, Revenue Misses In Q4

Investing.com - Merck&Co reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.

Merck&Co announced earnings per share of $1.16 on revenue of $11.87B. Analysts polled by Investing.com anticipated EPS of $1.15 on revenue of $11.95B. That with comparison to EPS of $1.04 on revenue of $11B in the same period a year before. Merck&Co had reported EPS of $1.51 on revenue of $12.4B in the previous quarter. Analysts are expecting EPS of $1.34 and revenue of $11.78B in the upcoming quarter.

Merck&Co shares are down 2.85% from the beginning of the year , still down 4.62% from its 52 week high of $92.64 set on December 20, 2019. They are under-performing the S&P Global 100 which is up 2.32% year to date.

Merck&Co follows other major Healthcare sector earnings this month

Merck&Co's report follows an earnings beat by J&J on January 22, who reported EPS of $1.88 on revenue of $20.75B, compared to forecasts EPS of $1.87 on revenue of $20.8B.

Novartis ADR had beat expectations on January 29 with fourth quarter EPS of $1.32 on revenue of $12.4B, compared to forecast for EPS of $1.31 on revenue of $12.33B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

Exclusive: HSBC to axe senior managers in strategy shift - sources

Stocks - U.S. Futures Jump on Virus Hopes; GM in Focus After Ford Slump

Spotify reports better-than-expected rise in premium subscribers